Berlin, Berlin, Germany
Entrepreneurial and purpose-driven General Manager with over 20 years of leadership experience across the DACH region in Specialty and Rare Diseases. Proven track record in building and transforming organizations, leading multiple first-to-market biologic launches, and driving sustainable business growth with full P&L accountability (€200M+). Combining strategic vision with hands-on leadership, I focus on enabling patient access, developing high-performing teams, and shaping market access excellence within complex healthcare systems. Deeply experienced in the German reimbursement and access landscape (AMNOG, G-BA) and recognized for fostering strong collaborations with payers, authorities, and medical experts. Passionate about creating agile, empowered organizations that operate with a biotech mindset—fast, accountable, and patient-centric. Core Expertise: General Management | P&L Leadership | Oncology | Neurology | Immunology | Rare Diseases | Market Access & Reimbursement | Commercial Strategy | Organizational Transformation | Launch Excellence | Cross-Country Leadership (Germany, Switzerland & Austria)